Analysis of a Norwegian cancer registry spanning five decades demonstrates, across nearly 50K patients with cutaneous squamous cell carcinoma (cSCC), those who were organ transplant recipients (n=1208) were far more likely to develop second cSCC (OR 4.3), develop mets (OR 1.5), and die from cSCC (OR 5.5) despite clearly higher competing risks of death. | Gjersvik, JAMA Dermatol 2023
